Leukodystrophies

Abstract

Leukodystrophies are heritable disorders primarily affecting the white matter of the central nervous system. They are clinically characterized by spasticity, optic atrophy, and ataxia. These are a heterogeneous group of disorders, including hypomyelinating disorders and demyelinating disorders due to abnormal accumulations. Although individually rare, together they are responsible for substantial disease burden. Essentially all these disorders have infantile, juvenile, and adult presentations. Understanding the genetic and biochemical bases of these disorders opens the door to therapeutic approaches.

Keywords

Pelizaeus-Merzbacher disease - metachromatic - Krabbe's disease - adrenoleukodystrophy - Canavan's disease - Alexander's disease

• References

• 1 Vanderver A, Prust M, Tonduti D , et al; GLIA Consortium. Case definition and classification of leukodystrophies and leukoencephalopathies. Mol Genet Metab 2015; 114 (4) 494-500
• 2 Bonkowsky JL, Nelson C, Kingston JL, Filloux FM, Mundorff MB, Srivastava R. The burden of inherited leukodystrophies in children. Neurology 2010; 75 (8) 718-725
• 3 Ahmed RM, Murphy E, Davagnanam I , et al. A practical approach to diagnosing adult onset leukodystrophies. J Neurol Neurosurg Psychiatry 2014; 85 (7) 770-781
• 4 Koeppen AH. A brief history of Pelizaeus-Merzbacher disease and proteolipid protein. J Neurol Sci 2005; 228 (2) 198-200
• 5 Hobson GM, Garbern JY. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders. Semin Neurol 2012; 32 (1) 62-67
• 6 Gruenenfelder FI, Thomson G, Penderis J, Edgar JM. Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease. J Anat 2011; 219 (1) 33-43
• 7 Gupta N, Henry RG, Strober J , et al. Neural stem cell engraftment and myelination in the human brain. Sci Transl Med 2012; 4 (155) 155ra137
• 8 Gieselmann V, Krageloh-Mann I. Metachromatic leukodystrophy. In: Raymond GV, Eichler F, Fatemi A, Naidu S, , eds. Leukodystrophies. London: Mac Keith Press; 2011: 130-155
• 9 van Rappard DF, Boelens JJ, Wolf NI. Metachromatic leukodystrophy: disease spectrum and approaches for treatment. Best Pract Res Clin Endocrinol Metab 2015; 29 (2) 261-273
• 10 Musolino PL, Lund TC, Pan J , et al. Hematopoietic stem cell transplantation in the leukodystrophies: a systematic review of the literature. Neuropediatrics 2014; 45 (3) 169-174
• 11 Wenger DA. Krabbe disease (globoid cell leukodystrophy). In: Raymond GV, Eichler F, Fatemi A, Naidu S, , eds. Leukodystrophies. London: Mac Keith Press; 2011: 90-105
• 12 Wenger DA, Rafi MA, Luzi P, Datto J, Costantino-Ceccarini E. Krabbe disease: genetic aspects and progress toward therapy. Mol Genet Metab 2000; 70 (1) 1-9
• 13 Abdelhalim AN, Alberico RA, Barczykowski AL, Duffner PK. Patterns of magnetic resonance imaging abnormalities in symptomatic patients with Krabbe disease correspond to phenotype. Pediatr Neurol 2014; 50 (2) 127-134
• 14 Duffner PK, Caggana M, Orsini JJ , et al. Newborn screening for Krabbe disease: the New York State model. Pediatr Neurol 2009; 40 (4) 245-252 , discussion 253–255
• 15 Escolar ML, Poe MD, Provenzale JM , et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 2005; 352 (20) 2069-2081
• 16 Raymond GV. X-linked adrenoleukodystrophy. In: Raymond GV, Eichler F, Fatemi A, Naidu S, , eds. Leukodystrophies. London: Mac Keith Press; 2011: 75-89
• 17 Engelen M, Kemp S, de Visser M , et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis 2012; 7: 51
• 18 Loes DJ, Fatemi A, Melhem ER , et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 2003; 61 (3) 369-374
• 19 Canavan MM. Schilder's encephalitis periaxialis diffusa: Report of a case in a child aged sixteen and one-half months. Arch Neurol Psychiatry 1931; 25: 299-308
• 20 Matalon R, Michals K, Sebesta D, Deanching M, Gashkoff P, Casanova J. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet 1988; 29 (2) 463-471
• 21 Kaul R, Gao GP, Balamurugan K, Matalon R. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat Genet 1993; 5 (2) 118-123
• 22 Matalon R, Michals K, Kaul R. Canavan disease: from spongy degeneration to molecular analysis. J Pediatr 1995; 127 (4) 511-517
• 23 McAdams HP, Geyer CA, Done SL, Deigh D, Mitchell M, Ghaed VN. CT and MR imaging of Canavan disease. AJNR Am J Neuroradiol 1990; 11 (2) 397-399
• 24 Chakraborty G, Mekala P, Yahya D, Wu G, Ledeen RW. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem 2001; 78 (4) 736-745
• 25 Alexander WS. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain 1949; 72 (3) 373-381 , 3
• 26 Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 2001; 27 (1) 117-120
• 27 Johnson AB, Brenner M. Alexander's disease: clinical, pathologic, and genetic features. J Child Neurol 2003; 18 (9) 625-632
• 28 Flint D, Brenner M. Alexander disease. In: Raymond GV, Eichler F, Fatemi A, Naidu S, , eds. Leukodystrophies. London: Mac Keith Press; 2011: 106-129
• 29 van der Knaap MS, Naidu S, Breiter SN , et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001; 22 (3) 541-552